This is pretty controversial in essence, if you have ever watched parent already getting pretty steamed up at baseball and soccer games, so next we could easily have some heated discussions on how long each child can play with parents feuding over who’s child has the best gene in the bunch and who would...
One of the founds is no other than James Thomson, an early stem cell pioneer, and the company just raised a few million more with investors, so all biomed is not in the same situation, I think it depends largely on what area of biomed is the focus. So in the future, maybe donate some DNA, grown...
Posted to
The Medical Quack .... by Barbara Duck
on 11-30-2008
Filed under: Medically Related, Technology, DNA, Genomics, Organs, R and D, Stem Cells, healthcare science, IPS Cells, drug reactions
Let’s put it another way, it can’t exist without IT. Again it all comes back to running algorithms to obtain desired results. As I have mentioned before, Algorithms is one of the hottest words right now in healthcare as we all make decisions from queried results. A while back I had the opportunity...
Posted to
The Medical Quack .... by Barbara Duck
on 11-25-2008
Filed under: Medically Related, Technology, Microsoft/Windows News, EMR, personalized medicine, DNA, Genomics, healthcare, microsoft, Medical Records, EHR, Health IT, Biotech, Pharmacogenomics, Helicos, Sequencing
The manufacturers of the machines that run our DNA are still very much in the forefront, gaining investors with DNA sequencing. BD NEW YORK (GenomeWeb News) – Menlo Park, Calif.-based Pacific Biosciences today said that it recently received $20 million in funding from new investor Blackstone Cleantech...
It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...
Posted to
The Medical Quack .... by Barbara Duck
on 08-14-2008
Filed under: Medically Related, Technology, My Commentaries, DNA, Genomics, Biotech, Research, Congress, Pharmaceuticals, Biosimilars
Dentists now are coming in to the fold of DNA genomics tests. This test is very specific to assess risk for periodontal disease, so as a younger patient, as chances are as we age if we are at risk we may already have this, this could be a good indicator for the dentist to have in the knowledge...
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
on 08-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test